SWM
Stockman Wealth Management Portfolio holdings
AUM
$736M
This Quarter Return
-8.9%
1 Year Return
+11.38%
3 Year Return
+50.59%
5 Year Return
+95.54%
10 Year Return
+167.07%
AUM
$392M
AUM Growth
+$392M
(-19%)
Cap. Flow
-$42.1M
Cap. Flow
% of AUM
-10.73%
Top 10 Holdings %
Top 10 Hldgs %
29.91%
Holding
199
New
3
Increased
76
Reduced
52
Closed
22
Top Buys
| 1 |
Amazon
AMZN
|
$4.07M |
| 2 |
Microsoft
MSFT
|
$3.33M |
| 3 |
Apple
AAPL
|
$1.85M |
| 4 |
Merck
MRK
|
$1.4M |
| 5 |
JPMorgan Chase
JPM
|
$1.06M |
Top Sells
Sector Composition
| 1 | Technology | 16.94% |
| 2 | Healthcare | 15.6% |
| 3 | Consumer Staples | 9.48% |
| 4 | Financials | 8.81% |
| 5 | Industrials | 7.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.77T
| $17.5M | 4.46% | 68,119 +12,958 | +23% | +$3.33M |
|
|
2
Apple
AAPL
$3.45T
| $16.6M | 4.24% | 121,496 +13,521 | +13% | +$1.85M |
|
3
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$5.3B
| $13.5M | 3.44% | 279,421 -885,934 | -76% | -$42.8M |
|
4
Berkshire Hathaway Class B
BRK.B
$1.09T
| $10.8M | 2.75% | 39,480 +1,396 | +4% | +$381K |
|
5
United States Oil Fund
USO
$967M
| $10.6M | 2.71% | 132,029 -850 | -0.6% | -$68.3K |
|
|
6
Merck
MRK
$210B
| $10.5M | 2.67% | 114,800 +15,325 | +15% | +$1.4M |
|
7
Exxon Mobil
XOM
$487B
| $9.89M | 2.52% | 115,526 -3,044 | -3% | -$261K |
|
8
Pfizer
PFE
$141B
| $9.41M | 2.4% | 179,450 +1,996 | +1% | +$105K |
|
9
Chevron
CVX
$324B
| $9.33M | 2.38% | 64,414 -1,734 | -3% | -$251K |
|
|
10
JPMorgan Chase
JPM
$829B
| $9.2M | 2.35% | 81,720 +9,448 | +13% | +$1.06M |
|
11
Procter & Gamble
PG
$368B
| $8.87M | 2.26% | 61,696 +1,350 | +2% | +$194K |
|
12
IBM
IBM
$227B
| $8.76M | 2.23% | 62,014 +1,119 | +2% | +$158K |
|
13
Invesco NASDAQ 100 ETF
QQQM
$58.8B
| $8.59M | 2.19% | 74,582 +6,172 | +9% | +$711K |
|
14
Intel
INTC
$107B
| $8.54M | 2.18% | 228,210 +18,703 | +9% | +$700K |
|
15
Cisco
CSCO
$274B
| $8.48M | 2.16% | 198,808 +18,141 | +10% | +$774K |
|
16
Bristol-Myers Squibb
BMY
$96B
| $8.11M | 2.07% | 105,303 -1,579 | -1% | -$122K |
|
17
US Bancorp
USB
$76B
| $8.1M | 2.07% | 175,959 +10,627 | +6% | +$489K |
|
18
AbbVie
ABBV
$372B
| $7.55M | 1.93% | 49,312 -135 | -0.3% | -$20.7K |
|
19
AT&T
T
$209B
| $7.19M | 1.83% | 343,172 +24,786 | +8% | +$520K |
|
20
Lockheed Martin
LMT
$106B
| $7.12M | 1.82% | 16,568 +168 | +1% | +$72.2K |
|
21
Kraft Heinz
KHC
$33.1B
| $7.11M | 1.81% | 186,367 +3,401 | +2% | +$130K |
|
22
CVS Health
CVS
$92.8B
| $6.93M | 1.77% | 74,731 +1,376 | +2% | +$128K |
|
23
3M
MMM
$82.8B
| $6.68M | 1.7% | 51,606 +3,845 | +8% | +$498K |
|
24
AB InBev
BUD
$122B
| $6.63M | 1.69% | 122,886 +5,877 | +5% | +$317K |
|
25
GSK
GSK
$79.9B
| $6.49M | 1.66% | 149,118 +2,900 | +2% | +$126K |
|